Publication:
Validation of the Toronto Psoriatic Arthritis Screen II (TOPAS II) questionnaire in a Turkish population

Simple item page
dc.contributor.authorŞANAL TOPRAK, CANAN
dc.contributor.authorsDuruoz, Mehmet Tuncay; Toprak, Canan Sanal; Ulutatar, Firat
dc.date.accessioned2022-03-12T22:24:18Z
dc.date.available2022-03-12T22:24:18Z
dc.date.issued2018
dc.description.abstractObjective To evaluate the TOPAS II questionnaire validation in a Turkish population. Methods The Turkish translation of ToPAS II was sent to us by the developer authors of the original index. Subjects were recruited from dermatology, physical medicine and rehabilitation, and rheumatology outpatient clinics. All patients' demographic parameters and ToPAS II questionnaire results were recorded. After patients completed the questionnaire they were assessed by a rheumatologist according to a standard protocol which includes a complete history, detailed physical examination, laboratory tests and CASPAR criteria. Receiver operating characteristics (ROC) assessed to obtain sensitivity and specificity of Turkish version of ToPAS II questionnaire. Results One hundred and fifty subjects were recruited in the study. The mean age of subjects was 41.07 years (SD 12.59) and the 58% of subjects were female. There were 46 subjects from psoriasis group, 43 subjects from psoriatic arthritis (PsA) group, 41 subjects from physical medicine and rehabilitation group and 20 subjects from rheumatology (non-PsA) group. The area under the ROC curve was 0.99 which means as excellent predictor and optimum cut-off threshold to discriminate patients diagnosed with PsA was 8 according to this ROC curve analysis. The overall sensitivity and specificity based on cut-off threshold of 8, were 95.8 and 98%, respectively. Conclusion The Turkish version of ToPAS II has high sensitivity and specificity. It is simple, not time consuming and useful tool to screen for PsA in both patients with and without psoriasis
dc.identifier.doi10.1007/s00296-017-3871-6
dc.identifier.eissn1437-160X
dc.identifier.issn0172-8172
dc.identifier.pubmed29116441
dc.identifier.urihttps://hdl.handle.net/11424/234729
dc.identifier.wosWOS:000422917100010
dc.language.isoeng
dc.publisherSPRINGER HEIDELBERG
dc.relation.ispartofRHEUMATOLOGY INTERNATIONAL
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPsoriatic arthritis
dc.subjectScreening tools
dc.subjectValidation
dc.subjectPsoriasis
dc.subjectRISK-FACTORS
dc.subjectVERSION
dc.subjectTOOLS
dc.titleValidation of the Toronto Psoriatic Arthritis Screen II (TOPAS II) questionnaire in a Turkish population
dc.typearticle
dspace.entity.typePublication
local.avesis.id4c1886bf-53fe-4026-a05a-01e1d4598583
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.journal.numberofpages5
local.journal.quartileQ3
oaire.citation.endPage259
oaire.citation.issue2
oaire.citation.startPage255
oaire.citation.titleRHEUMATOLOGY INTERNATIONAL
oaire.citation.volume38
relation.isAuthorOfPublicationcd325669-ecc3-489c-81ff-618c4f13c2a2
relation.isAuthorOfPublication.latestForDiscoverycd325669-ecc3-489c-81ff-618c4f13c2a2

Files

Collections

Research Outputs